Effectiveness of Sitagliptin in Asian Indian Patients with Type 2 Diabetes—An Indian Tertiary Diabetes Care Center Experience-Reference-Cited by-同舟云学术

Effectiveness of Sitagliptin in Asian Indian Patients with Type 2 Diabetes—An Indian Tertiary Diabetes Care Center Experience

Published:2011-01 Issue:1 Volume:13 Page:27-32
ISSN:1520-9156
Container-title:Diabetes Technology & Therapeutics
language:en
Short-container-title:Diabetes Technology & Therapeutics

Author:

Sudhakaran Chidambarann¹,Kishore Utkal¹,Anjana Ranjit Mohan¹,Unnikrishnan Ranjit¹,Mohan Viswanathan¹

Affiliation:

1. Dr. Mohan's Diabetes Specialities Centre & Madras Diabetes Research Foundation, WHO Collaborating Centre for Non-communicable Diseases and International Diabetes Federation Centre of Education, Gopalapuram, Chennai, India.

Publisher

Mary Ann Liebert Inc

Subject

Medical Laboratory Technology,Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://www.liebertpub.com/doi/pdf/10.1089/dia.2010.0120

Reference37 articles.

1. 1. Unwin N, Whiting D, Gan D, Jacqmain O, Ghyoot G, eds. IDF Diabetes Atlas, 4thed. Brussels: International Diabetes Federation, 2009:11–13.

2. Epidemiology of Cardiovascular Disease in Type 2 Diabetes: The Indian Scenario

3. Global estimates of the prevalence of diabetes for 2010 and 2030

4. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

5. Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vildagliptin plasticized hydrogel film in the control of ocular inflammation after topical application: study of hydration and erosion behaviour;Zeitschrift für Physikalische Chemie;2021-08-06

2. Precision Diabetes Is Slowly Becoming a Reality;Medical Principles and Practice;2019

3. Comparative Safety of Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas and Other Glucose-lowering Therapies for Three Acute Outcomes;Scientific Reports;2018-10-11

4. Evaluation of pharmacokinetic and pharmacodynamic parameters following single dose of sitagliptin in healthy Indian males;European Journal of Clinical Pharmacology;2018-03-06

5. Dipeptidyl peptidase-4 inhibitors, pancreatic cancer and acute pancreatitis: A meta-analysis with trial sequential analysis;Scientific Reports;2018-01-15